探索NAFLD的多方面代谢病理和机制:文献计量学分析和深入回顾。

IF 2.6 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Xinyi Jiao, Haitao Wang, Rongrong Li, Tekleab Teka, Zhifei Fu, Haiyang Yu, Jie Li, Rui Su, Lifeng Han
{"title":"探索NAFLD的多方面代谢病理和机制:文献计量学分析和深入回顾。","authors":"Xinyi Jiao, Haitao Wang, Rongrong Li, Tekleab Teka, Zhifei Fu, Haiyang Yu, Jie Li, Rui Su, Lifeng Han","doi":"10.2174/0113816128350055250224055446","DOIUrl":null,"url":null,"abstract":"<p><p>Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome, affecting about a quarter of the world's population. As the prevalence of obesity and metabolic syndrome rises, NAFLD is projected to become the leading cause of cirrhosis in the coming years. NAFLD is a complex disease whose pathophysiology mainly focuses on metabolic dysfunction and intestinal microecological dysregulation. Shifts between free fatty acid (FFA) metabolism and cell damage could be of major interest in finding new therapeutic targets. However, current public understanding of these diseases remains limited. Based on bibliometrics and extensive studies, this study explored the mechanisms by which FFAs regulate the occurrence of NAFLD. This review not only focuses on the role of the vicious cycle derived from FFA metabolic disorders, ecological disorders, and liver damage immunity concerning diabetes mellitus type 2 and NAFLD but also discusses the mechanisms involved in them.</p>","PeriodicalId":10845,"journal":{"name":"Current pharmaceutical design","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploring the Multifaceted Metabolic Pathology and Mechanisms of NAFLD: A Bibliometric Analysis and an In-depth Review.\",\"authors\":\"Xinyi Jiao, Haitao Wang, Rongrong Li, Tekleab Teka, Zhifei Fu, Haiyang Yu, Jie Li, Rui Su, Lifeng Han\",\"doi\":\"10.2174/0113816128350055250224055446\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome, affecting about a quarter of the world's population. As the prevalence of obesity and metabolic syndrome rises, NAFLD is projected to become the leading cause of cirrhosis in the coming years. NAFLD is a complex disease whose pathophysiology mainly focuses on metabolic dysfunction and intestinal microecological dysregulation. Shifts between free fatty acid (FFA) metabolism and cell damage could be of major interest in finding new therapeutic targets. However, current public understanding of these diseases remains limited. Based on bibliometrics and extensive studies, this study explored the mechanisms by which FFAs regulate the occurrence of NAFLD. This review not only focuses on the role of the vicious cycle derived from FFA metabolic disorders, ecological disorders, and liver damage immunity concerning diabetes mellitus type 2 and NAFLD but also discusses the mechanisms involved in them.</p>\",\"PeriodicalId\":10845,\"journal\":{\"name\":\"Current pharmaceutical design\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-04-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current pharmaceutical design\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/0113816128350055250224055446\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pharmaceutical design","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113816128350055250224055446","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

非酒精性脂肪性肝病(NAFLD)是代谢综合征的肝脏表现,影响着世界上约四分之一的人口。随着肥胖和代谢综合征患病率的上升,预计NAFLD将在未来几年成为肝硬化的主要原因。NAFLD是一种复杂的疾病,其病理生理主要表现为代谢功能障碍和肠道微生态失调。游离脂肪酸(FFA)代谢和细胞损伤之间的变化可能是寻找新的治疗靶点的主要兴趣。然而,目前公众对这些疾病的了解仍然有限。基于文献计量学和广泛的研究,本研究探讨了FFAs调节NAFLD发生的机制。本文综述了游离脂肪酸代谢紊乱、生态紊乱和肝损伤免疫的恶性循环在2型糖尿病和NAFLD中的作用,并对其机制进行了探讨。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exploring the Multifaceted Metabolic Pathology and Mechanisms of NAFLD: A Bibliometric Analysis and an In-depth Review.

Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome, affecting about a quarter of the world's population. As the prevalence of obesity and metabolic syndrome rises, NAFLD is projected to become the leading cause of cirrhosis in the coming years. NAFLD is a complex disease whose pathophysiology mainly focuses on metabolic dysfunction and intestinal microecological dysregulation. Shifts between free fatty acid (FFA) metabolism and cell damage could be of major interest in finding new therapeutic targets. However, current public understanding of these diseases remains limited. Based on bibliometrics and extensive studies, this study explored the mechanisms by which FFAs regulate the occurrence of NAFLD. This review not only focuses on the role of the vicious cycle derived from FFA metabolic disorders, ecological disorders, and liver damage immunity concerning diabetes mellitus type 2 and NAFLD but also discusses the mechanisms involved in them.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.30
自引率
0.00%
发文量
302
审稿时长
2 months
期刊介绍: Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field. Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信